ResearcherUniversity of ToyamaActive in the last 2 years

Takeyoshi Yamazaki

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5046148384. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 1 paper

Papers 1

Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluations. Co-author DOI 10.1021/acs.jmedchem.4c01141 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nguyễn Duy Phan · 1 shared paper, 2024 · strength 0.21
- Paper Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluat… DOI 10.1021/acs.jmedchem.4c01141 ↗
Suresh Awale · 1 shared paper, 2024 · strength 0.21
- Paper Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluat… DOI 10.1021/acs.jmedchem.4c01141 ↗
Naoki Toyooka · 1 shared paper, 2024 · strength 0.21
- Paper Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluat… DOI 10.1021/acs.jmedchem.4c01141 ↗
Juthamart Maneenet · 1 shared paper, 2024 · strength 0.21
- Paper Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluat… DOI 10.1021/acs.jmedchem.4c01141 ↗
Takuya Okada · 1 shared paper, 2024 · strength 0.21
- Paper Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluat… DOI 10.1021/acs.jmedchem.4c01141 ↗
Tsutomu Fujii · 1 shared paper, 2024 · strength 0.21
- Paper Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluat… DOI 10.1021/acs.jmedchem.4c01141 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.